Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interrogating androgen receptor function in recurrent prostate cancer.

Liqun Zhang1, Mai Johnson, Kim H Le

  • 1Departments of Biological Chemistry, University of California Los Angeles School of Medicine, Los Angeles, CA 90095, USA.

Cancer Research
|August 9, 2003
PubMed
Summary

Androgen receptor (AR) signaling is crucial in prostate cancer. This study reveals AR remains fully functional during recurrent prostate cancer, even after androgen withdrawal, facilitating tumor regrowth.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approaching Social Determinants of Health in Otolaryngology - Head Neck Surgery: Linking Needs to Resources to Promote Health Equity.

ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses·2025
Same author

Post-traumatic growth, resilience, perceived social support, and coping style among parents of very low birth weight infants: a multi-center, cross-sectional study.

Frontiers in public health·2025
Same author

Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells.

Cell reports. Medicine·2025
Same author

Lessons Learned From Bhutan on extending Girls-Only HPV Vaccination Program to Boys: A Qualitative Study.

Asia-Pacific journal of public health·2024
Same author

A Rare Case of Recurrent Intrahepatic Cholestasis of Pregnancy With Prolonged Postpartum Hepatic Inflammation Despite Normalization of Bile Acid Levels.

Gastro hep advances·2024
Same author

Exosomes from Von Hippel-Lindau-Null Cancer Cells Promote Metastasis in Renal Cell Carcinoma.

International journal of molecular sciences·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Androgen receptor (AR) signaling drives early prostate cancer.
  • AR functionality in recurrent prostate cancer post-androgen withdrawal is not fully understood.

Purpose of the Study:

  • To investigate AR signaling activity in androgen-dependent (AD) and recurrent prostate cancer xenografts.
  • To determine if AR remains functional during prostate cancer recurrence.

Main Methods:

  • Utilized molecular imaging with a luciferase reporter system in mouse xenografts.
  • Performed chromatin immunoprecipitation and immunohistochemistry to assess AR localization and binding.
  • Tracked AR transcriptional activity during the transition from AD to recurrent cancer.

Related Experiment Videos

Main Results:

  • AR transcriptional activity was lost upon castration and resumed during recurrent growth.
  • AR translocated to the nucleus and bound the prostate-specific antigen enhancer in recurrent tumors.
  • RNA polymerase II and TFIIB remained bound to the gene throughout the transition, suggesting a poised complex.

Conclusions:

  • Androgen receptor (AR) is fully functional in recurrent prostate cancer.
  • A poised transcription complex may facilitate AR reactivation at low ligand levels during recurrence.
  • This provides insight into mechanisms driving prostate cancer progression after treatment.